T2 Biosystems (TTOO): Debts to Book Capitalization

Fierce competition for hospital government budgets has led to volatility, as evidenced by the peak on the chart. The current share of T2 Biosystems, Inc. (TTOO) debt in the balance sheet capitalization 0.00 is becoming a new value for this metric. T2 Biosystems, Inc. (TTOO) leads in rapid sepsis diagnostics thanks to T2MR technology, which reduces analysis time to 3 hours. The business is currently restructuring its liabilities, focusing on scaling IT platforms for pathogen detection.

TTOO T2 Biosystems, Inc. Debt to Book Value Ratio (07/04/2022 - 02/22/2025)

Summary analytical data breakdowns for T2 Biosystems Inc. (TTOO)

- price and consensus price forecast:

Stock Price T2 Biosystems, Inc.|TTOO - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization T2 Biosystems Inc|TTOO - Full Takeover Company Value

- book capitalization data:

Net Assets per Single Share T2 Biosystems|TTOO - Accounting Capitalization|Market Value to Book Value Ratio t2biosystems.com|TTOO - Company Assets

- debt and liquidity data:

Debt to Equity T2 Biosystems, Inc.|TTOO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio T2 Biosystems, Inc|TTOO - Company Cumulative Indebtedness|Debts to Book Capitalization T2 Biosystems Inc

Fundamental company analysis:T2 Biosystems, Inc.

This ratio is calculated as total debt obligations divided by total equity on the balance sheet. The metric determines the business's dependence on debt financing and the level of insolvency risk. For T2 Biosystems, Inc. (TTOO), excessive leverage is dangerous amid geopolitical barriers limiting the export of diagnostic systems. Reducing the debt load increases resilience to falling sales. By analyzing the history of debt-to-equity ratios, an investor assesses the balance between financial risk and return.

Competitors of T2 Biosystems, Inc.